Clinical Trials in Fujian, Fujian
3 recruiting
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Breast Neoplasms
Merck Sharp & Dohme LLC1,000 enrolled149 locationsNCT07060807
Recruiting
Phase 2
HS-20093 in Patients with Advanced Esophageal Carcinoma and Other Advanced Solid Tumors
Advanced Solid Tumor
Hansoh BioMedical R&D Company220 enrolled21 locationsNCT06112704
Recruiting
Phase 2
A Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma
Intrahepatic Cholangiocarcinoma (Icc)
Beijing InnoCare Pharma Tech Co., Ltd.70 enrolled44 locationsNCT05678270